Aug 12, 2026 · 17 min · 11 segments
Ahead of his EURETINA Lecture in Vienna — "The Dark Side of the Moon: New Horizons in Dry AMD" — Past President Prof. Frank Holz joins President Prof. Nicole Eter for a wide-ranging conversation on…
Frank HolzGuest
Nicole EterGuest
Jonathan McRaeHost
And well, today I have the great pleasure of speaking with Professor Frank Holtz.

He's past president of Uretina, as you already mentioned, and the leading figure in retinal research and particularly in age-related macular degeneration.

Frank, you are a professor and chairman of the Department of Ophthalmology at the University of Bonn.

And early in your career, you spent time at Moorfields Eye Hospital in London, working with Professor Ellen Bird.

And I guess that's an experience that helped you shape your subsequent scientific interests in macular disease.

So over the past decades, you and your group have made major contributions to our understanding of geographic atrophy and dry AMD from fundus autofluorescence, retinal imaging, to disease phenotyping, biomarkers, and to national history studies, and also to the development of new therapeutic approaches.

So this year, you have been invited to give the prestigious Euretina Lecture in Vienna.

And the title is intriguing and also very fitting, The Dark Side of the Moon, New Horizons in Dry AMD.

Now, if you compare what you thought the disease was when you started with how you see it today, what has changed most fundamentally?

And well, today I have the great pleasure of speaking with Professor Frank Holtz.

He's past president of Uretina, as you already mentioned, and the leading figure in retinal research and particularly in age-related macular degeneration.

Frank, you are a professor and chairman of the Department of Ophthalmology at the University of Bonn.

And early in your career, you spent time at Moorfields Eye Hospital in London, working with Professor Ellen Bird.

And I guess that's an experience that helped you shape your subsequent scientific interests in macular disease.

So over the past decades, you and your group have made major contributions to our understanding of geographic atrophy and dry AMD from fundus autofluorescence, retinal imaging, to disease phenotyping, biomarkers, and to national history studies, and also to the development of new therapeutic approaches.

So this year, you have been invited to give the prestigious Euretina Lecture in Vienna.

And the title is intriguing and also very fitting, The Dark Side of the Moon, New Horizons in Dry AMD.

Now, if you compare what you thought the disease was when you started with how you see it today, what has changed most fundamentally?
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.